Listed

Bioventus Inc.

BVSNasdaqCIK 1665988HealthcareFiscal year ends Dec 31

Latest reported revenue, Q2 FY2026$153.2mRevenue, Q2 FY2026, three months to 2026-06-27$153.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001665988-26-000042.Report this figureThree months to Jun 27, 2026, from the 10-Q filed Aug 5, 2026.

Latest quarter: Q2 FY2026

Three months to Jun 27, 2026, against the same quarter a year earlier.

  • Revenue$153.2mRevenue, Q2 FY2026, three months to 2026-06-27$153.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001665988-26-000042.Report this figure+3.8% on a year earlier
  • Gross margin69.0%Gross margin, Q2 FY2026, three months to 2026-06-27. gross profit / revenueGross profit: $105.7m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-05, accession 0001665988-26-000042.Revenue: $153.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001665988-26-000042.Report this figure−0.2 pts on a year earlier
  • Operating margin12.5%Operating margin, Q2 FY2026, three months to 2026-06-27. operating income / revenueOperating income: $19.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001665988-26-000042.Revenue: $153.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001665988-26-000042.Report this figure+0.0 pts on a year earlier
  • Net margin21.8%Net margin, Q2 FY2026, three months to 2026-06-27. net income / revenueNet income: $33.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001665988-26-000042.Revenue: $153.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001665988-26-000042.Report this figure+16.8 pts on a year earlier
  • Diluted EPS$0.47Diluted EPS, Q2 FY2026, three months to 2026-06-27$0.47 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001665988-26-000042.Report this figure+327.3% on a year earlier
  • Free cash flow$18.9mFree cash flow, Q2 FY2026, three months to 2026-06-27. operating cash flow − capital expenditureOperating cash flow: $19.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001665988-26-000042. Derived: 6-month figure less the 3-month figure.Capital expenditure: $960.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0001665988-26-000042. Derived: 6-month figure less the 3-month figure.Report this figure−25.1% on a year earlier

Last eight quarters

Full statements
Revenue$153.2mGross margin 69.0%
Diluted EPS$0.47, Q2 FY2026
Free cash flow$18.9m, Q2 FY2026
Bioventus Inc., key figures for the last eight quarters
Line itemUnitQ3 FY20242024-09-28Q4 FY20242024-12-31Q1 FY20252025-03-29Q2 FY20252025-06-28Q3 FY20252025-09-27Q4 FY20252025-12-31Q1 FY20262026-03-28Q2 FY20262026-06-27Shape over the periods
Revenue$m139Revenue, Q3 FY2024, three months to 2024-09-28$139.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-04, accession 0001665988-25-000026.Report this figure154Revenue, Q4 FY2024, three months to 2024-12-31$153.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-05, accession 0001665988-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure124Revenue, Q1 FY2025, three months to 2025-03-29$123.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001665988-26-000027.Report this figure148Revenue, Q2 FY2025, three months to 2025-06-28$147.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001665988-26-000042.Report this figure139Revenue, Q3 FY2025, three months to 2025-09-27$138.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-04, accession 0001665988-25-000026.Report this figure158Revenue, Q4 FY2025, three months to 2025-12-31$157.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-05, accession 0001665988-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure132Revenue, Q1 FY2026, three months to 2026-03-28$132.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001665988-26-000027.Report this figure153Revenue, Q2 FY2026, three months to 2026-06-27$153.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001665988-26-000042.Report this figure
Gross margin%67.3%Gross margin, Q3 FY2024, three months to 2024-09-28. gross profit / revenueGross profit: $93.6m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-04, accession 0001665988-25-000026.Revenue: $139.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-04, accession 0001665988-25-000026.Report this figure66.8%Gross margin, Q4 FY2024, three months to 2024-12-31. gross profit / revenueGross profit: $102.7m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-05, accession 0001665988-26-000011. Derived: 12-month figure less the 9-month figure.Revenue: $153.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-05, accession 0001665988-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure67.0%Gross margin, Q1 FY2025, three months to 2025-03-29. gross profit / revenueGross profit: $83.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-06, accession 0001665988-26-000027.Revenue: $123.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001665988-26-000027.Report this figure69.1%Gross margin, Q2 FY2025, three months to 2025-06-28. gross profit / revenueGross profit: $102.1m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-05, accession 0001665988-26-000042.Revenue: $147.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001665988-26-000042.Report this figure68.0%Gross margin, Q3 FY2025, three months to 2025-09-27. gross profit / revenueGross profit: $94.2m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-04, accession 0001665988-25-000026.Revenue: $138.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-04, accession 0001665988-25-000026.Report this figure68.9%Gross margin, Q4 FY2025, three months to 2025-12-31. gross profit / revenueGross profit: $108.8m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-05, accession 0001665988-26-000011. Derived: 12-month figure less the 9-month figure.Revenue: $157.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-05, accession 0001665988-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure68.7%Gross margin, Q1 FY2026, three months to 2026-03-28. gross profit / revenueGross profit: $90.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-06, accession 0001665988-26-000027.Revenue: $132.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001665988-26-000027.Report this figure69.0%Gross margin, Q2 FY2026, three months to 2026-06-27. gross profit / revenueGross profit: $105.7m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-05, accession 0001665988-26-000042.Revenue: $153.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001665988-26-000042.Report this figure
Operating margin%2.6%Operating margin, Q3 FY2024, three months to 2024-09-28. operating income / revenueOperating income: $3.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-04, accession 0001665988-25-000026.Revenue: $139.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-04, accession 0001665988-25-000026.Report this figure5.0%Operating margin, Q4 FY2024, three months to 2024-12-31. operating income / revenueOperating income: $7.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-05, accession 0001665988-26-000011. Derived: 12-month figure less the 9-month figure.Revenue: $153.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-05, accession 0001665988-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure3.9%Operating margin, Q1 FY2025, three months to 2025-03-29. operating income / revenueOperating income: $4.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001665988-26-000027.Revenue: $123.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001665988-26-000027.Report this figure12.4%Operating margin, Q2 FY2025, three months to 2025-06-28. operating income / revenueOperating income: $18.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001665988-26-000042.Revenue: $147.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001665988-26-000042.Report this figure8.1%Operating margin, Q3 FY2025, three months to 2025-09-27. operating income / revenueOperating income: $11.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-04, accession 0001665988-25-000026.Revenue: $138.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-04, accession 0001665988-25-000026.Report this figure12.3%Operating margin, Q4 FY2025, three months to 2025-12-31. operating income / revenueOperating income: $19.5m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-05, accession 0001665988-26-000011. Derived: 12-month figure less the 9-month figure.Revenue: $157.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-05, accession 0001665988-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure6.4%Operating margin, Q1 FY2026, three months to 2026-03-28. operating income / revenueOperating income: $8.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-06, accession 0001665988-26-000027.Revenue: $132.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001665988-26-000027.Report this figure12.5%Operating margin, Q2 FY2026, three months to 2026-06-27. operating income / revenueOperating income: $19.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-05, accession 0001665988-26-000042.Revenue: $153.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001665988-26-000042.Report this figure
Net margin%(3.7%)Net margin, Q3 FY2024, three months to 2024-09-28. net income / revenueNet income: −$5.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001665988-25-000026.Revenue: $139.0m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-04, accession 0001665988-25-000026.Report this figure(0.3%)Net margin, Q4 FY2024, three months to 2024-12-31. net income / revenueNet income: −$388.0k. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-05, accession 0001665988-26-000011. Derived: 12-month figure less the 9-month figure.Revenue: $153.6m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-05, accession 0001665988-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure(2.1%)Net margin, Q1 FY2025, three months to 2025-03-29. net income / revenueNet income: −$2.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-06, accession 0001665988-26-000027.Revenue: $123.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001665988-26-000027.Report this figure5.1%Net margin, Q2 FY2025, three months to 2025-06-28. net income / revenueNet income: $7.5m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001665988-26-000042.Revenue: $147.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001665988-26-000042.Report this figure2.3%Net margin, Q3 FY2025, three months to 2025-09-27. net income / revenueNet income: $3.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-04, accession 0001665988-25-000026.Revenue: $138.7m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2025-11-04, accession 0001665988-25-000026.Report this figure9.3%Net margin, Q4 FY2025, three months to 2025-12-31. net income / revenueNet income: $14.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-05, accession 0001665988-26-000011. Derived: 12-month figure less the 9-month figure.Revenue: $157.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-05, accession 0001665988-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure2.4%Net margin, Q1 FY2026, three months to 2026-03-28. net income / revenueNet income: $3.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-06, accession 0001665988-26-000027.Revenue: $132.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-05-06, accession 0001665988-26-000027.Report this figure21.8%Net margin, Q2 FY2026, three months to 2026-06-27. net income / revenueNet income: $33.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-05, accession 0001665988-26-000042.Revenue: $153.2m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-Q filed 2026-08-05, accession 0001665988-26-000042.Report this figure
Diluted EPS$ per share(0.08)Diluted EPS, Q3 FY2024, three months to 2024-09-28−$0.08 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-04, accession 0001665988-25-000026.Report this figurenot reported (Diluted EPS not reported)(0.04)Diluted EPS, Q1 FY2025, three months to 2025-03-29−$0.04 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001665988-26-000027.Report this figure0.11Diluted EPS, Q2 FY2025, three months to 2025-06-28$0.11 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001665988-26-000042.Report this figure0.05Diluted EPS, Q3 FY2025, three months to 2025-09-27$0.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-04, accession 0001665988-25-000026.Report this figurenot reported (Diluted EPS not reported)0.04Diluted EPS, Q1 FY2026, three months to 2026-03-28$0.04 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-06, accession 0001665988-26-000027.Report this figure0.47Diluted EPS, Q2 FY2026, three months to 2026-06-27$0.47 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-05, accession 0001665988-26-000042.Report this figure
Free cash flow$m10.3Free cash flow, Q3 FY2024, three months to 2024-09-28. operating cash flow − capital expenditureOperating cash flow: $10.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-04, accession 0001665988-25-000026. Derived: 9-month figure less the 6-month figure.Capital expenditure: $64.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-04, accession 0001665988-25-000026. Derived: 9-month figure less the 6-month figure.Report this figure18.7Free cash flow, Q4 FY2024, three months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $19.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-05, accession 0001665988-26-000011. Derived: 12-month figure less the 9-month figure.Capital expenditure: $574.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-05, accession 0001665988-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure(20.2)Free cash flow, Q1 FY2025, three months to 2025-03-29. operating cash flow − capital expenditureOperating cash flow: −$19.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001665988-26-000027.Capital expenditure: $826.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-06, accession 0001665988-26-000027.Report this figure25.3Free cash flow, Q2 FY2025, three months to 2025-06-28. operating cash flow − capital expenditureOperating cash flow: $25.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001665988-26-000042. Derived: 6-month figure less the 3-month figure.Capital expenditure: $683.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0001665988-26-000042. Derived: 6-month figure less the 3-month figure.Report this figure29.6Free cash flow, Q3 FY2025, three months to 2025-09-27. operating cash flow − capital expenditureOperating cash flow: $30.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-04, accession 0001665988-25-000026. Derived: 9-month figure less the 6-month figure.Capital expenditure: $473.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-04, accession 0001665988-25-000026. Derived: 9-month figure less the 6-month figure.Report this figure37.4Free cash flow, Q4 FY2025, three months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $38.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-05, accession 0001665988-26-000011. Derived: 12-month figure less the 9-month figure.Capital expenditure: $580.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-05, accession 0001665988-26-000011. Derived: 12-month figure less the 9-month figure.Report this figure8.4Free cash flow, Q1 FY2026, three months to 2026-03-28. operating cash flow − capital expenditureOperating cash flow: $8.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-06, accession 0001665988-26-000027.Capital expenditure: $574.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-06, accession 0001665988-26-000027.Report this figure18.9Free cash flow, Q2 FY2026, three months to 2026-06-27. operating cash flow − capital expenditureOperating cash flow: $19.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-05, accession 0001665988-26-000042. Derived: 6-month figure less the 3-month figure.Capital expenditure: $960.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-05, accession 0001665988-26-000042. Derived: 6-month figure less the 3-month figure.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$568.1mGross margin 68.3%
Diluted EPS$0.33, FY2025
Free cash flow$72.1m, FY2025
Bioventus Inc., key figures for the last five fiscal years
Line itemUnitFY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31Shape over the periods
Revenue$m431Revenue, FY2021, twelve months to 2021-12-31$430.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-03-12, accession 0001628280-24-010376.Report this figure512Revenue, FY2022, twelve months to 2022-12-31$512.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-11, accession 0001628280-25-011831.Report this figure512Revenue, FY2023, twelve months to 2023-12-31$512.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-05, accession 0001665988-26-000011.Report this figure573Revenue, FY2024, twelve months to 2024-12-31$573.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-05, accession 0001665988-26-000011.Report this figure568Revenue, FY2025, twelve months to 2025-12-31$568.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-05, accession 0001665988-26-000011.Report this figure
Gross margin%70.3%Gross margin, FY2021, twelve months to 2021-12-31. gross profit / revenueGross profit: $302.7m. XBRL concept us-gaap:GrossProfit. 10-K filed 2024-03-12, accession 0001628280-24-010376.Revenue: $430.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-03-12, accession 0001628280-24-010376.Report this figure64.6%Gross margin, FY2022, twelve months to 2022-12-31. gross profit / revenueGross profit: $331.1m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-03-11, accession 0001628280-25-011831.Revenue: $512.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-11, accession 0001628280-25-011831.Report this figure64.1%Gross margin, FY2023, twelve months to 2023-12-31. gross profit / revenueGross profit: $328.2m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-05, accession 0001665988-26-000011.Revenue: $512.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-05, accession 0001665988-26-000011.Report this figure67.7%Gross margin, FY2024, twelve months to 2024-12-31. gross profit / revenueGross profit: $388.2m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-05, accession 0001665988-26-000011.Revenue: $573.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-05, accession 0001665988-26-000011.Report this figure68.3%Gross margin, FY2025, twelve months to 2025-12-31. gross profit / revenueGross profit: $388.2m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-03-05, accession 0001665988-26-000011.Revenue: $568.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-05, accession 0001665988-26-000011.Report this figure
Operating margin%2.8%Operating margin, FY2021, twelve months to 2021-12-31. operating income / revenueOperating income: $12.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-03-12, accession 0001628280-24-010376.Revenue: $430.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-03-12, accession 0001628280-24-010376.Report this figure(32.7%)Operating margin, FY2022, twelve months to 2022-12-31. operating income / revenueOperating income: −$167.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-03-11, accession 0001628280-25-011831.Revenue: $512.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-11, accession 0001628280-25-011831.Report this figure(16.0%)Operating margin, FY2023, twelve months to 2023-12-31. operating income / revenueOperating income: −$81.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-05, accession 0001665988-26-000011.Revenue: $512.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-05, accession 0001665988-26-000011.Report this figure(2.7%)Operating margin, FY2024, twelve months to 2024-12-31. operating income / revenueOperating income: −$15.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-05, accession 0001665988-26-000011.Revenue: $573.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-05, accession 0001665988-26-000011.Report this figure9.5%Operating margin, FY2025, twelve months to 2025-12-31. operating income / revenueOperating income: $54.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-05, accession 0001665988-26-000011.Revenue: $568.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-05, accession 0001665988-26-000011.Report this figure
Net margin%4.5%Net margin, FY2021, twelve months to 2021-12-31. net income / revenueNet income: $19.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-03-12, accession 0001628280-24-010376.Revenue: $430.9m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2024-03-12, accession 0001628280-24-010376.Report this figure(31.0%)Net margin, FY2022, twelve months to 2022-12-31. net income / revenueNet income: −$158.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-03-11, accession 0001628280-25-011831.Revenue: $512.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2025-03-11, accession 0001628280-25-011831.Report this figure(30.5%)Net margin, FY2023, twelve months to 2023-12-31. net income / revenueNet income: −$156.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-05, accession 0001665988-26-000011.Revenue: $512.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-05, accession 0001665988-26-000011.Report this figure(6.3%)Net margin, FY2024, twelve months to 2024-12-31. net income / revenueNet income: −$36.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-05, accession 0001665988-26-000011.Revenue: $573.3m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-05, accession 0001665988-26-000011.Report this figure4.0%Net margin, FY2025, twelve months to 2025-12-31. net income / revenueNet income: $22.7m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-05, accession 0001665988-26-000011.Revenue: $568.1m. XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. 10-K filed 2026-03-05, accession 0001665988-26-000011.Report this figure
Diluted EPS$ per share(0.15)Diluted EPS, FY2021, twelve months to 2021-12-31−$0.15 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-03-12, accession 0001628280-24-010376.Report this figure(2.59)Diluted EPS, FY2022, twelve months to 2022-12-31−$2.59 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-03-11, accession 0001628280-25-011831.Report this figure(2.49)Diluted EPS, FY2023, twelve months to 2023-12-31−$2.49 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-05, accession 0001665988-26-000011.Report this figure(0.56)Diluted EPS, FY2024, twelve months to 2024-12-31−$0.56 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-05, accession 0001665988-26-000011.Report this figure0.33Diluted EPS, FY2025, twelve months to 2025-12-31$0.33 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-03-05, accession 0001665988-26-000011.Report this figure
Free cash flow$m9.5Free cash flow, FY2021, twelve months to 2021-12-31. operating cash flow − capital expenditureOperating cash flow: $23.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2024-03-12, accession 0001628280-24-010376.Capital expenditure: $13.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2024-03-12, accession 0001628280-24-010376.Report this figure(15.0)Free cash flow, FY2022, twelve months to 2022-12-31. operating cash flow − capital expenditureOperating cash flow: −$13.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-03-11, accession 0001628280-25-011831.Capital expenditure: $1.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-03-11, accession 0001628280-25-011831.Report this figure8.0Free cash flow, FY2023, twelve months to 2023-12-31. operating cash flow − capital expenditureOperating cash flow: $15.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-05, accession 0001665988-26-000011.Capital expenditure: $7.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-05, accession 0001665988-26-000011.Report this figure37.8Free cash flow, FY2024, twelve months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $38.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-05, accession 0001665988-26-000011.Capital expenditure: $1.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-05, accession 0001665988-26-000011.Report this figure72.1Free cash flow, FY2025, twelve months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $74.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-05, accession 0001665988-26-000011.Capital expenditure: $2.6m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-05, accession 0001665988-26-000011.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding Bioventus Inc.
FundQuarter endedReported valueSharesPut or callChange on the quarter before
Essex Woodlands Management, Inc.2026-06-30$122.9m13,021,324Unchanged
Juniper Investment Company, LLC2026-06-30$65.5m6,939,357Unchanged
Nantahala Capital Management, LLC2026-06-30$56.6m6,000,279Reduced−122,124
Nantahala Capital Management, LLC2026-06-30$56.6m6,000,279Reduced−122,124
BlackRock, Inc.2026-06-30$32.4m3,435,914Added+302,373
ROYCE & ASSOCIATES LP2026-06-30$17.3m1,833,212Added+291,930
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$16.5m1,751,678Added+36,971
GEODE CAPITAL MANAGEMENT, LLC2026-06-30$12.9m1,365,716Added+197,469
AMERICAN CENTURY COMPANIES INC2026-06-30$12.8m1,353,415Added+733,612
DIMENSIONAL FUND ADVISORS LP2026-06-30$10.7m1,128,465Added+255,327

Recent filings

All 457 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

Bioventus Inc., recent filings
FiledFormWhat it isAccession number
2026-08-0507:43 ET10-QQuarterly reportPeriod 2026-06-270001665988-26-000042
2026-08-0507:40 ET8-K2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits0001665988-26-000041
2026-06-0407:54 ET8-K5.07 Shareholder vote results0001665988-26-000035
2026-05-2116:58 ET8-K7.01 Regulation FD disclosure0001665988-26-000029
2026-05-0607:48 ET10-QQuarterly reportPeriod 2026-03-280001665988-26-000027
2026-05-0607:46 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001665988-26-000026
2026-04-2207:51 ETDEF 14AProxy statementPeriod 2025-12-310001665988-26-000014
2026-03-0507:37 ET10-KAnnual reportPeriod 2025-12-310001665988-26-000011
2026-03-0507:34 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001665988-26-000010
2025-11-1717:04 ET8-K5.02 Departure or appointment of officers or directors0001665988-25-000032

Latest annual report

Form 10-K for the fiscal year ended Dec 31, 2025Filed Mar 5, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Q3 FY2026, the quarter ended 2026-09-27, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by [object Promise].Forecast this quarter

About the filer

CIK
1665988
Tickers
BVS
Exchange
Nasdaq
SIC code
3841 Surgical & Medical Instruments & Apparatus
Sector
Healthcare
Fiscal year ends
Dec 31
Incorporated in
DE
Filer category
Accelerated filer<br>Emerging growth company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 27, 2026, 17:28 ET. Listed shows no prices and gives no investment advice.